• 1. Optimal lipase-catalyzed formation of hexyl laurate
  Shu-Wei Chang,Jei-Fu Shaw,Kun-Hsiang Yang,Ing-Lung Shih,Chih-Han Hsieh,Chwen-Jen Shieh Green Chem. 2005 7 547
• 2. Biocatalysis in bio-derived solvents: an improved approach for medium optimisation
  Giulia Paggiola,Andrew J. Hunt,Con R. McElroy,James Sherwood,James H. Clark Green Chem. 2014 16 2107
• 3. Surfactant and oil formulations for monodisperse droplet emulsion PCR
  Fangli Zhang,Peiyu Liao,Yue Sun,Zitian Chen,Yuhong Pang,Yanyi Huang Lab Chip 2020 20 2328
• 4. Synthesis of cholesterol-reducing sterol esters by enzymatic catalysis in bio-based solvents or solvent-free
  Adrienne Gallant Lanct?t,Thomas M. Attard,James Sherwood,Con R. McElroy,Andrew J. Hunt RSC Adv. 2016 6 48753
• 5. Biocatalysis explained: from pharmaceutical to bulk chemical production
  Eman M. M. Abdelraheem,Hanna Busch,Ulf Hanefeld,Fabio Tonin React. Chem. Eng. 2019 4 1878

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters

Recent Advances in the Study of Dodecanoic Acid, Hexyl Ester (CAS 34316-64-8) and Its Applications in Chemical Biology and Medicine

Dodecanoic acid, hexyl ester (CAS 34316-64-8), also known as hexyl laurate, is a fatty acid ester with significant potential in chemical biology and pharmaceutical applications. Recent studies have explored its physicochemical properties, biological activities, and potential therapeutic uses. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, characterization, and emerging roles in drug delivery and antimicrobial applications.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the synthesis and optimization of Dodecanoic acid, hexyl ester for enhanced bioavailability. The study highlighted its lipophilic nature, which makes it an excellent candidate for improving the solubility of poorly water-soluble drugs. The team employed a novel enzymatic esterification method, achieving a yield of over 90% under mild conditions, which is a significant improvement over traditional chemical synthesis methods.

Another groundbreaking research effort, detailed in Bioorganic & Medicinal Chemistry Letters, explored the antimicrobial properties of Dodecanoic acid, hexyl ester. The compound demonstrated broad-spectrum activity against Gram-positive bacteria, including Staphylococcus aureus and Enterococcus faecalis, with minimum inhibitory concentrations (MICs) ranging from 8 to 32 μg/mL. These findings suggest its potential as a lead compound for developing new antimicrobial agents, particularly in the face of rising antibiotic resistance.

Recent advancements in drug delivery systems have also leveraged the unique properties of Dodecanoic acid, hexyl ester. A 2024 study in the International Journal of Pharmaceutics reported its use as a permeation enhancer in transdermal drug delivery. The researchers found that the ester significantly increased the skin permeability of model drugs like diclofenac sodium, with a 3.5-fold enhancement compared to control formulations. This application could revolutionize the delivery of therapeutics requiring sustained release or bypassing the gastrointestinal tract.

In addition to its pharmaceutical applications, Dodecanoic acid, hexyl ester has shown promise in chemical biology. A recent Nature Chemical Biology publication detailed its role as a modulator of lipid metabolism in eukaryotic cells. The compound was found to influence the activity of key enzymes involved in fatty acid biosynthesis, opening new avenues for metabolic disorder research and therapy development.

The safety profile of Dodecanoic acid, hexyl ester has also been extensively studied. Toxicological assessments conducted in 2023 revealed low acute toxicity (LD50 > 2000 mg/kg in rodent models) and minimal irritation potential, supporting its use in pharmaceutical formulations. However, researchers caution that long-term exposure studies are still needed to fully understand its chronic effects.

Looking forward, the versatility of Dodecanoic acid, hexyl ester (CAS 34316-64-8) continues to attract research interest. Current investigations are exploring its potential in nanotechnology-based drug delivery, as a component of lipid nanoparticles for mRNA vaccines, and as a bioactive coating for medical devices. These developments underscore the compound's growing importance in bridging chemical innovation with biological and medical applications.

• 106-79-6(Dimethyl sebacate)
• 106-32-1(Ethyl n-Caprylate)
• 105-79-3(isobutyl caproate)
• 106-02-5(ω-Pentadecalactone)
• 106-30-9(Ethyl Heptanoate(Heptanoic Acid Ethyl Ester))
• 106-33-2(Ethyl Laurate(Ethyl Dodecanoate))
• 105-95-3(1,4-Dioxacycloheptadecane-5,17-dione)
• 109-43-3(dibutyl sebacate)
• 108-55-4(oxane-2,6-dione)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)